Document ID: chunk:federal_register_of_legislation:F2021C00104:front:0:p3
Version: federal_register_of_legislation:F2021C00104
Segment Type: other
Provision Reference: 
Character Range: 5615–8939

3.17 The CEO to engage an interpreter
3.18 The CEO to pay athlete's expenses
3.19 Retired athletes
3.20 What athlete may do before giving sample
3.21 Right to a representative
Division 3.4—Analysing samples
3.22 What the CEO may do with samples
3.23 The CEO may ask laboratory to test samples
3.24 World Anti‑Doping Code procedures to be followed
3.26 Ownership of samples
Division 3.4A—Request to attend interview, give information or produce documents
3.26A Request
Division 3.4B—Requirement to attend interview, give information or produce documents
3.26B Requirement
3.26C Form and conduct of an interview
3.26E Retaining and copying documents produced in response to a disclosure notice
Division 3.5—Investigations
3.27 Investigations
Part 4—Results management
Division 4.1—Adverse analytical findings
4.01 Review by CEO
Division 4.2—Other anti‑doping rule violations
4.07A Dealing with possible non‑presence anti‑doping rule violation
Division 4.3—Assertions about anti‑doping rule violations
4.08 Assertions about anti‑doping rule violations
4.13 Presentation of cases
Division 4.4—Disclosure of information
4.17 Notifying sporting administration bodies etc. about assertions
4.21 Disclosing information etc. obtained in relation to administration of the NAD scheme
4.22 Publishing information relating to assertions
4.22A Other publications permitted by the World Anti‑Doping Code
Division 4.5—Commencing action against an athlete, support person or non‑participant
4.23 Limitations provision for commencing action
Division 4.6—Violations List
4.24 Correcting entries in the Violations List
Part 5—ASDMAC functions
5.01 Functions of ASDMAC
Part 5A—Retired athletes
5A.01 Application of NAD scheme to retired athletes returning to competition
Part 6—Miscellaneous
6.01 When notices are taken to have been received
6.02 Waiver of Rights
6.03 Fees
Part 7—Application and transitional provisions
Division 1—Amendments made by the Australian Sports Anti‑Doping Authority Amendment (World Anti‑Doping Code and Other Measures) Regulation 2014
7.01 Definitions
7.02 Anti‑doping rule violations occurring before commencement of amending regulation
7.03 Prohibited association anti‑doping rule violations
Division 2—Amendments made by the Australian Sports Anti‑Doping Authority Amendment (Sport Integrity Australia) Regulations 2020
7.04 Functions and powers of CEO
7.05 Identity cards
7.06 ASADA representatives
7.07 Notices
7.08 Retired athletes
7.09 Possible non‑presence anti‑doping rule violations
Division 3—Amendments made by the Sport Integrity Australia Amendment (Enhancing Australia's Anti‑Doping Capability) Regulations 2020
7.10 Anti‑Doping Rule Violation Panel
Division 4—Amendments made by the Sport Integrity Australia Amendment (World Anti‑Doping Code Review) Regulations 2020
7.11 Classes of persons who compete in sport or have competed in sport in the last 6 months subject to the NAD scheme
7.12 Classes of support persons subject to the NAD scheme
7.13 Non‑participants subject to the NAD scheme
7.14 Anti‑doping rules
7.15 Testing and investigating
7.16 Results management
Schedule 2—Relevant international anti‑doping instruments
Endnotes
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Endnote 5—Editorial changes

Part 1—Introductory